Analysis Article • Aug 09
Have your own idea? Try our Stock Screener
Brazilian (BOVESPA) Drug Retail Industry Analysis
UpdatedAug 24, 2026
DataAggregated Company Financials
Companies4
- 7D4.9%
- 3M-2.5%
- 1Y0.8%
- YTDn/a
The Drug Retail industry is up 4.9% in the last week, with Raia Drogasil up 6.7%. Despite this gain, the industry's performance has been flat over the past year. Looking forward, earnings are forecast to grow by 20% annually.
Industry Valuation and Performance
Has the Brazilian Drug Retail Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Mon, 24 Aug 2026 | R$36.7b | R$70.8b | R$1.9b | 13.6x | 19.4x | 0.5x |
| Wed, 22 Jul 2026 | R$36.2b | R$69.4b | R$1.8b | 13.1x | 20.5x | 0.5x |
| Fri, 19 Jun 2026 | R$33.6b | R$69.4b | R$1.8b | 13.3x | 19x | 0.5x |
| Sun, 17 May 2026 | R$39.5b | R$69.4b | R$1.8b | 13.3x | 22.3x | 0.6x |
| Tue, 14 Apr 2026 | R$48.2b | R$67.3b | R$1.7b | 16.5x | 28.3x | 0.7x |
| Thu, 12 Mar 2026 | R$48.7b | R$67.0b | R$1.7b | 20.1x | 28.9x | 0.7x |
| Sat, 07 Feb 2026 | R$52.5b | R$64.4b | R$1.6b | 27.7x | 33.6x | 0.8x |
| Mon, 05 Jan 2026 | R$47.7b | R$64.4b | R$1.6b | 25.3x | 30.5x | 0.7x |
| Wed, 03 Dec 2025 | R$47.6b | R$64.4b | R$1.6b | 24.9x | 30.4x | 0.7x |
| Fri, 31 Oct 2025 | R$38.2b | R$62.2b | R$1.4b | 20.5x | 27x | 0.6x |
| Sun, 28 Sep 2025 | R$34.4b | R$62.2b | R$1.4b | 19x | 24.3x | 0.6x |
| Tue, 26 Aug 2025 | R$35.0b | R$62.2b | R$1.4b | 19.1x | 24.7x | 0.6x |
| Thu, 24 Jul 2025 | R$28.1b | R$60.2b | R$1.3b | 17.4x | 21x | 0.5x |
| Sat, 21 Jun 2025 | R$27.7b | R$60.2b | R$1.3b | 17.1x | 20.7x | 0.5x |
| Mon, 19 May 2025 | R$29.6b | R$60.1b | R$1.3b | 17.9x | 22.1x | 0.5x |
| Wed, 16 Apr 2025 | R$42.5b | R$58.6b | R$1.3b | 22.5x | 32x | 0.7x |
| Fri, 14 Mar 2025 | R$35.2b | R$58.3b | R$1.5b | 12.7x | 24.1x | 0.6x |
| Sun, 09 Feb 2025 | R$37.8b | R$56.7b | R$1.4b | 11.4x | 26.9x | 0.7x |
| Tue, 07 Jan 2025 | R$39.0b | R$56.7b | R$1.4b | 12.1x | 27.7x | 0.7x |
| Thu, 05 Dec 2024 | R$44.8b | R$56.7b | R$1.4b | 12.4x | 31.9x | 0.8x |
| Sat, 02 Nov 2024 | R$45.2b | R$54.9b | R$1.3b | 16.7x | 36x | 0.8x |
| Mon, 30 Sep 2024 | R$47.5b | R$54.8b | R$1.3b | 16.3x | 37.9x | 0.9x |
| Wed, 28 Aug 2024 | R$51.3b | R$54.8b | R$1.3b | 18.5x | 40.9x | 0.9x |
| Fri, 26 Jul 2024 | R$48.0b | R$53.1b | R$1.2b | 29.3x | 39.7x | 0.9x |
| Sun, 23 Jun 2024 | R$47.4b | R$53.1b | R$1.2b | 28.4x | 39.2x | 0.9x |
| Tue, 21 May 2024 | R$51.2b | R$53.1b | R$1.2b | 20.4x | 41x | 1x |
| Thu, 18 Apr 2024 | R$46.2b | R$51.4b | R$1.2b | 29.2x | 39.5x | 0.9x |
| Sat, 16 Mar 2024 | R$49.9b | R$51.4b | R$1.2b | 31.5x | 42.7x | 1x |
| Mon, 12 Feb 2024 | R$47.1b | R$49.8b | R$1.1b | 20.4x | 44.5x | 0.9x |
| Wed, 10 Jan 2024 | R$54.0b | R$49.8b | R$1.1b | 22x | 51x | 1.1x |
| Fri, 08 Dec 2023 | R$53.1b | R$49.8b | R$1.1b | 20.9x | 50.1x | 1.1x |
| Sun, 05 Nov 2023 | R$46.9b | R$49.3b | R$997.0m | 20.1x | 47.1x | 1x |
| Tue, 03 Oct 2023 | R$50.7b | R$48.1b | R$948.8m | 20.7x | 53.4x | 1.1x |
| Thu, 31 Aug 2023 | R$51.6b | R$48.1b | R$948.8m | 22.7x | 54.4x | 1.1x |
Price to Earnings Ratio
54.4x
Current Industry PE
- Investors are pessimistic on the Brazilian Drug Retail industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 19.4x which is lower than its 3-year average PE of 33.5x.
- The industry is trading close to its 3-year average PS ratio of 0.76x.
Past Earnings Growth
- The earnings for companies in the Drug Retail industry have grown 26% per year over the last three years.
- Revenues for these companies have grown 14% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Comparison
How does Brazilian Drug Retail compare with similar industries?
| BR Market | 2.01% | |
| Consumer Staples | 4.42% | |
| Food and Staples Retail | 4.53% | |
| Drug Retail | 4.85% | |
| Big Box Super Stores | 3.96% | |
| Food Retail | 0% | 0 |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| RADL3 Raia Drogasil | R$18.43 | 6.7% +R$2.0b | 3.8% | PE23x | |
| PNVL3 Dimed Distribuidora de Medicamentos | R$11.51 | 3.8% +R$62.7m | 14.3% | PE12.5x |
